Researchers discovered that digested SARS-CoV-2 spike protein fragments selectively attack certain immune cells, reducing ...

A new hypothesis article was published in Oncotarget (Volume 17) on January 3, 2026, titled “Hypothesis: HPV E6 and COVID spike proteins cooperate in targeting tumor suppression by p53.” ...

Multiple randomized clinical trials and electronic health record studies now show that metformin, a widely used and well-established medication, significantly reduces the risk of developing long COVID ...

Multiple randomized clinical trials and health record studies show that taking metformin during or soon after SARS-CoV-2 infection lowers the risk of long COVID. This makes metformin the first ...

Multiple randomized clinical trials and electronic health record studies now show that metformin, a widely used and ...

Are you one of the women who suffered from Covid? There is a shocking link that has appeared between the disease and ...

Older women who have a history of both depression and anxiety had a 78% higher risk of developing long COVID after a SARS-CoV-2 infection, report University of California San Diego researchers in the ...

Phase 2 clinical trial will evaluate the safety, translational biology, and exploratory clinical efficacy of VYD2311 in people with Long COVID or ...

Nature’s annual list of technologies to watch is a chance to celebrate progress and stimulate research into both ...